DRI Healthcare Comments on Juvmo's (tavapadon) FDA Approval

TORONTO, Sept. 28, 2026 /CNW/ -- DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) ("DRI Healthcare") today commented on the U.S. Food and Drug Administration's ("FDA") recently announced approval of Juvmo (tavapadon) for the treatment of motor symptoms that occur in Parkinson's disease. Juvmo (tavap…